TAK-101: A Drug for Celiac Disease?

Welcome to our June 2021 Celiac Research Briefing! This month we’re talking about a study looking at a drug for celiac disease. It’s very exciting to see more drugs being tested for celiac disease and it hopefully means that in the not-too-distant future there will be a viable alternative to the gluten-free diet for the millions of people living with celiac disease around the world. As usual, we have our Director of Research, Dr. Jocelyn Silvester here to answer lots of questions about this drug trial. Study Title: TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study https://pubmed.ncbi.nlm.nih.gov/33722...